These findings indicate that METTL1 regulates the accumulation of immunosuppressive cells via chemokine translation (64), representing a key mechanism underlying immune evasion and therapeutic resistance in ICC, and providing a potential target to enhance ICI efficacy. This evidence concerns the gene METTL1 and intrahepatic cholangiocarcinoma.